医中誌リンクサービス


文献リスト

1)Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001; 34: 651-8
PubMed CrossRef
医中誌リンクサービス
2)Nakanuma Y, Sasaki M, Ishikawa A, et al. Biliary papillary neoplasms of the liver. Histol Histopathol. 2002; 17: 851-61
PubMed
医中誌リンクサービス
3)Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology. 2006; 44: 1333-43
PubMed CrossRef
医中誌リンクサービス
4)Nakanuma Y, Curado M-P, Franceschi S, et al. WHO classification of tumors of the digestive system, 4th ed. Lyon : WHO; 2010. p.217-24
医中誌リンクサービス
5)日本肝胆膵外科学会,編.臨床・病理 胆道癌取扱い規約第6版.東京: 金原出版; 2013
医中誌リンクサービス
6)Shibahara H, Tamada S, Goto M, et al. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2004; 28: 332-8
医中誌リンクサービス
7)Nakanuma Y, Sato Y, Ojima H, et al. Clinicopathological characterization of so-called “cholangiocarcinoma with intraductal papillary growth” with respect to “intraductal papillary neoplasm of bile duct (IPNB)”. Int J Clin Exp Pathol. 2014; 7: 3112-22
PubMed
医中誌リンクサービス
8)Ohtsuka M, Shimizu H, Kato A, et al. Intraductal papillary neoplasms of the bile duct. Int J Hepatol. 2014; 2014: 459091. doi: 10.1155/2014/ 459091
医中誌リンクサービス
9)Ohtsuka M, Kimura F, Shimizu H, et al. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg pathol. 2011; 35: 512-21
PubMed CrossRef
医中誌リンクサービス
10)Kubota K, Nakanuma Y, Kondo F, et al. Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. J Hepatobiliary Pancreat Sci. 2014; 21: 176-85
PubMed CrossRef
医中誌リンクサービス
11)Wan XS, Xu YY, Qian JY, et al. Intraductal papillary neoplasm of the bile duct. World J Gastroenterol. 2013; 19: 8595-604
PubMed CrossRef
医中誌リンクサービス
12)Jung G, Park KM, Lee SS, et al. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct. J Hepatology. 2012; 57: 787-93
PubMed CrossRef
医中誌リンクサービス
13)Ogawa H, Itoh S, Ngasaka T, et al. CT findings of intraductal papillary neoplasm of the bile duct: Assessment with multiphase contrast-enhanced examination using multi-ditector CT. Clin Radiol. 2012; 67: 224-31
PubMed CrossRef
医中誌リンクサービス
14)Yoon HJ, Kim YK, Jang KT, et al. Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI. Abdominal Imaging. 2013; 38: 1082-90
PubMed CrossRef
医中誌リンクサービス
15)Tsuyuguchi T, Sakai Y, Sugiyama H, et al. Endoscopic diagnosis intraductal papillary neoplasm of the bile duct. J Hepatobiliary Pancreat Sci. 2010; 17: 230-5
PubMed CrossRef
医中誌リンクサービス
16)Schlitter AM, Born D, Bettstetter M, et al. Intraductal papillary neoplasm of the bile duct: stepwise progression to carcinoma involves common molecular pathways. Mod Pathol. 2014; 27: 73-86
PubMed CrossRef
医中誌リンクサービス
17)Nakanishi Y, Zen Y, Kondo S, et al. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Human Pathol. 2008; 39: 1153-61
PubMed CrossRef
医中誌リンクサービス
18)Sasaki M, Matsubara T, Yoneda N, et al. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct. Histopathology. 2013; 62: 446-57
PubMed CrossRef
医中誌リンクサービス
19)Matthaei H, Wu J, Dal Molin M, et al. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB. 2012; 14: 677-83
PubMed CrossRef
医中誌リンクサービス
20)Sasaki M, Matsubara T, Nitta T, et al. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct. PLoS One. 2013; 8: e81706
CrossRef
医中誌リンクサービス
21)Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011; 1: 161. doi: 10.1038/srep00161
医中誌リンクサービス
22)Tsai JH, Yuan RH, Chen YL, et al. GNAS is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct. Am J Surg Pathol. 2013; 37: 1862-70
PubMed CrossRef
医中誌リンクサービス
23)Wakai T, Shirai Y, Moroda T, et al. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005; 15: 1210-6
医中誌リンクサービス
24)Kim KM, Lee JK, Shin JU, et al. Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype. Am J Gastroenterol. 2012; 107: 118-25
PubMed CrossRef
医中誌リンクサービス
25)Onoe S, Shimoyama Y, Ebata T, et al. Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients. Surgery. 2014; 155: 280-91
PubMed CrossRef
医中誌リンクサービス
26)Mano Y, Aishima S, Fujita N, et al. Cystic tumors of the liver: On the problems of diagnostic criteria. Pathol Res Pract. 2011; 42: 1531-8
医中誌リンクサービス


NPO医学中央雑誌刊行会
https://www.jamas.or.jp/
info@jamas.or.jp